Skip to content

Hypoglycemic effect of Mooviladi kashaya in Type 2 Diabetes mellitus

Effect of Mooviladi kashaya in Type 2 Diabetes mellitus. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073022
Enrollment
30
Registered
2024-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

None listed

Sponsors

STEFY JOSEPH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants fulfilling the diagnostic criteria Participants diagnosed with Type 2 Diabetes mellitus within 2 years Participants willing to sign the informed consent form Participants having any or both the blood glucose levels with following ranges FBS - 126mg/dl to 250mg/dl RBS- 200mg/dl to 350mg/dl

Exclusion criteria

Exclusion criteria: Participants diagnosed with Type 1 Diabetes mellitus Participants who are known case of other systemic illness Participants who are known cases of psychiatric illness Pregnant and lactating women HbA1c greater than 8.5

Design outcomes

Primary

MeasureTime frame
FBS RBS Polyuria Polyphagia Polydipsia Excessive Sweating FatigueTimepoint: Assessment on 0th and 31st day

Secondary

MeasureTime frame
Quality of LifeTimepoint: Assessment on 0th & 31st day

Countries

India

Contacts

Public ContactDr Vinitha C

Poomulli Neelakandan Namboodiripad Memorial Ayurveda Medical College and Hospital

drsurej@gmail.com8943438383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026